Autor: "Liu GG" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Evidence-based decision-making on medical technologies in China, Japan, and Singapore.
Autorzy:: Liu GG; Peking University Guanghua School of Management, Beijing, China. />Fukuda T
Lee CE
Chen V
Zheng Q
Kamae I; Pokaż więcej
Źródło:: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2009 Nov-Dec; Vol. 12 Suppl 3, pp. S12-7.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Device Approval*
Drug Approval/*economics
Evidence-Based Medicine/*economics
National Health Programs/*economics
China ; Cost-Benefit Analysis ; Humans ; Japan ; Prospective Payment System/legislation & jurisprudence ; Singapore

Czasopismo naukowe

Skocz do pozycji: 2.

Tytuł:: Emerging health economics and outcomes research in the Asia-Pacific region.
Autorzy:: Liu GG
Eggleston K
Hu TW; Pokaż więcej
Źródło:: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2008 Mar; Vol. 11 Suppl 1, pp. S1-2.
Typ publikacji:: Editorial; Introductory Journal Article
MeSH Terms:: Economics, Medical*
Health Services Research*
Outcome Assessment, Health Care*
Asia, Southeastern ; Economics, Pharmaceutical ; Humans

Czasopismo naukowe

Skocz do pozycji: 3.

Tytuł:: What is next for pharmacoeconomics and outcomes research in Asia?
Autorzy:: Doherty J; Pharmacia Inc., Tokyo, Japan.
Kamae I
Lee KK
Li H
Li SC
Liu GG
Tarn YH
Yang BM; Pokaż więcej
Źródło:: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2004 Mar-Apr; Vol. 7 (2), pp. 118-32.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Economics, Pharmaceutical/*trends
Outcome Assessment, Health Care/*trends
Aged ; Asia ; Delivery of Health Care ; Female ; Health Expenditures ; Health Status Indicators ; Humans ; Male ; Middle Aged

Czasopismo naukowe

Skocz do pozycji: 4.

Tytuł:: How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance.
Autorzy:: Guo JD; Pharmaceutical Policy and Evaluative Sciences, University of North Carolina at Chapel Hill, 27599-7360, USA.
Liu GG
Christensen DB
Fu AZ; Pokaż więcej
Źródło:: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2003 Jan-Feb; Vol. 6 (1), pp. 18-28.
Typ publikacji:: Journal Article
MeSH Terms:: Practice Guidelines as Topic*
Antihypertensive Agents/*therapeutic use
Drug Prescriptions/*standards
Drug Utilization/*statistics & numerical data
Guideline Adherence/*statistics & numerical data
Insurance, Pharmaceutical Services/*statistics & numerical data
Practice Patterns, Physicians'/*statistics & numerical data
Adrenergic beta-Antagonists/therapeutic use ; Aged ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Antihypertensive Agents/classification ; Antihypertensive Agents/economics ; Calcium Channel Blockers/therapeutic use ; Causality ; Cross-Sectional Studies ; Diuretics/therapeutic use ; Drug Therapy, Combination ; Drug Utilization/economics ; Female ; Guideline Adherence/economics ; Health Care Surveys ; Humans ; Insurance, Pharmaceutical Services/classification ; Logistic Models ; Male ; Middle Aged ; Patient Selection ; Practice Patterns, Physicians'/economics ; Retrospective Studies ; United States

Czasopismo naukowe

Informacja